Biotechnology company Tidal Vision said it closed an oversubscribed $140 million Series B financing round. Participants in the round included Cambridge Companies SPG, Eni Next, Convent Capital, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback